TP53 and neoplasm: When human HCT116 (p53−/−) cells with SOCS2 knocked down were subcutaneously injected into both flanks of nude mice, after 3 weeks of injections, SOCS2 knockdown cells elicited an antitumor effect, significantly suppressing tumor growth, compared to mice injected with control cells (Fig. 3c).